Cencora, Inc.
A large pharmaceutical distributor that moves branded, generic, and over-the-counter medicines from drugmakers to hospitals, retail pharmacies, and long-term care facilities around the world. The company was born from the 2001 merger of two drug wholesalers, AmeriSource Health and Bergen Brunswig, and kept the combined name AmerisourceBergen until August 2023, when it rebranded as Cencora to signal its global reach. A telling detail: its old name simply stitched the two founding companies' names together.
Granted 12.6K
Granted 905 · Bought 8.0K
Granted 12.6K
Granted 8.4K
Granted 557
Granted 673
Granted 656 · Bought 550
Granted 557
Granted 557
Granted 557
Granted 557
Granted 557
Granted 656
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Cleary James FChief Financial Officer · 2 transactions | +4.7% | 160.4K | 12.6K | — | — |
| Durcan Dermot MarkDirector · 3 transactions | +39% | 31.8K | 905 | 8.0K | — |
| Campbell Elizabeth SExecutive Vice President · 2 transactions | +28.3% | 30.7K | 12.6K | — | — |
| Battaglia SilvanaExecutive Vice President · 2 transactions | +44.7% | 27.2K | 8.4K | — | — |
| Greenberg Lon RDirector · 1 transaction | +3.1% | 18.4K | 557 | — | — |
| Nally Dennis MDirector · 2 transactions | +5.4% | 13.1K | 673 | — | — |
| Tyler Lauren MDirector · 3 transactions | +38.2% | 4.4K | 656 | 550 | — |
| Kim Lorence H.Director · 1 transaction | +15.8% | 4.1K | 557 | — | — |
| Miller RedondaDirector · 1 transaction | +17.4% | 3.8K | 557 | — | — |
| Baumann WernerDirector · 1 transaction | +17.8% | 3.7K | 557 | — | — |
| Clyburn FrankDirector · 1 transaction | +47.7% | 1.7K | 557 | — | — |
| Ryerkerk LoriDirector · 1 transaction | +107.9% | 1.1K | 557 | — | — |
| Cooper EllenDirector · 2 transactions | +975.7% | 796 | 656 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: +8.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.